Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
2020 · Journal of Clinical Oncology · 1,151 citations
https://doi.org/10.1200/jco.20.01888
J
Jia Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
531
Papers
11.5K
Citations
56
h-index
207
i10-index
Jia Chen is an academic researcher from Tongji University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Birth, Development, and Health & MicroRNA in disease regulation. The author has an h-index of 56, co-authored 452 publications.
ORCID: 0000-0001-6597-8577Papers by this author
worksMaternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors
2019 · Nature Genetics · 631 citations
https://doi.org/10.1038/s41588-019-0403-1
Prenatal exposure to benzophenones, parabens and triclosan and neurocognitive development at 2 years
2019 · Environment International · 92 citations
https://doi.org/10.1016/j.envint.2019.01.023
Urinary concentrations of environmental phenols and their associations with breast cancer incidence and mortality following breast cancer
2019 · Environment International · 91 citations
https://doi.org/10.1016/j.envint.2019.05.084
The effectiveness of case management for cancer patients: an umbrella review
2022 · BMC Health Services Research · 88 citations
https://doi.org/10.1186/s12913-022-08610-1
<scp>SGLT2</scp> inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the <scp>HIF</scp> ‐2α signaling pathway in arrhythmogenic cardiomyopathy
2022 · The FASEB Journal · 69 citations
https://doi.org/10.1096/fj.202200243r
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat